World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
28832
World Ranking
13610
National Ranking
6916

Overview

Rachel Schiff is affiliated with Baylor College of Medicine in the United States. Their research spans medicine and biochemistry, genetics and molecular biology, with significant contributions to oncology and molecular biology subfields. Their work also encompasses pulmonary and respiratory medicine, radiology, nuclear medicine and imaging, and cancer research.

Their research topics focus predominantly on HER2/EGFR in cancer research, advanced breast cancer therapies, monoclonal and polyclonal antibodies research, cancer-related molecular pathways, cancer treatment and pharmacology, FOXO transcription factor regulation, and cancer genomics and diagnostics.

The scientist has published extensively in several notable venues including:

  • Cancer Research
  • Clinical Cancer Research
  • Journal of Clinical Oncology
  • The FASEB Journal
  • UNC Libraries

Rachel Schiff has frequently collaborated with several coauthors, including:

  • Mothaffar F. Rimawi
  • Jamunarani Veeraraghavan
  • Sarmistha Nanda
  • Carmine De Angelis
  • Xiaoyong Fu

Their recent papers include:

  • HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis, 2020, Cancer Treatment Reviews
  • Enhancer reprogramming driven by high-order assemblies of transcription factors promotes phenotypic plasticity and breast cancer endocrine resistance, 2020, Nature Cell Biology
  • Microscaled proteogenomic methods for precision oncology, 2020, Nature Communications
  • The bone microenvironment increases phenotypic plasticity of ER+ breast cancer cells, 2021, Developmental Cell
  • Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibition, 2020, Science Advances

Best Publications

  • Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer.

    Jiang Shou;Suleiman Massarweh;C. Kent Osborne;Alan E. Wakeling

  • Mechanisms of Endocrine Resistance in Breast Cancer

    C. Kent Osborne;Rachel Schiff

  • Role of the Estrogen Receptor Coactivator AIB1 (SRC-3) and HER-2/neu in Tamoxifen Resistance in Breast Cancer

    C. Kent Osborne;Valerie Bardou;Torsten A. Hopp;Gary C. Chamness

  • Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT complexes

    Robert M. Lavinsky;Kristen Jepsen;Thorsten Heinzel;Joseph Torchia

  • The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo

    Kristen L. Meerbrey;Guang Hu;Jessica D. Kessler;Kevin Roarty

  • HER2: biology, detection, and clinical implications.

    Carolina Gutierrez;Rachel Schiff

  • Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance

    Grazia Arpino;Lisa Wiechmann;C. Kent Osborne;Rachel Schiff

  • Biology of Progesterone Receptor Loss in Breast Cancer and Its Implications for Endocrine Therapy

    Xiaojiang Cui;Rachel Schiff;Grazia Arpino;C. Kent Osborne

  • ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer

    Rinath Jeselsohn;Gilles Buchwalter;Carmine De Angelis;Myles Brown

  • Molecular Changes in Tamoxifen-Resistant Breast Cancer: Relationship Between Estrogen Receptor, HER-2, and p38 Mitogen-Activated Protein Kinase

    M. Carolina Gutierrez;Simone Detre;Stephen Johnston;Syed K. Mohsin

  • Estrogen Receptor–Positive, Progesterone Receptor–Negative Breast Cancer: Association With Growth Factor Receptor Expression and Tamoxifen Resistance

    Grazia Arpino;Heidi Weiss;Adrian V. Lee;Rachel Schiff

  • Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic Function

    Suleiman Massarweh;C. Kent Osborne;Chad J. Creighton;Lanfang Qin

  • Crosstalk between estrogen receptor and growth factor receptor pathways as a cause for endocrine therapy resistance in breast cancer.

    C. Kent Osborne;Jiang Shou;Suleiman Massarweh;Rachel Schiff

  • Cross-Talk between Estrogen Receptor and Growth Factor Pathways as a Molecular Target for Overcoming Endocrine Resistance

    Rachel Schiff;Suleiman A. Massarweh;Jiang Shou;Lavina Bharwani

  • A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models

    Xiaomei Zhang;Sofie Claerhout;Aleix Prat;Lacey E. Dobrolecki

  • Estrogen-Receptor Biology: Continuing Progress and Therapeutic Implications

    C. Kent Osborne;Rachel Schiff

  • A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.

    Jessica D. Kessler;Kristopher T. Kahle;Kristopher T. Kahle;Tingting Sun;Kristen L. Meerbrey

  • Breast Cancer Endocrine Resistance How Growth Factor Signaling and Estrogen Receptor Coregulators Modulate Response

    Rachel Schiff;Suleiman Massarweh;Jiang Shou;C. Kent Osborne

  • MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis

    Atsushi Terunuma;Nagireddy Putluri;Prachi Mishra;Ewy A. Mathé

  • Au Nanomatryoshkas as Efficient Near-Infrared Photothermal Transducers for Cancer Treatment: Benchmarking against Nanoshells

    Ciceron Ayala-Orozco;Cordula Urban;Mark W. Knight;Alexander Skyrme Urban

Frequent Co-Authors

C. Kent Osborne
C. Kent Osborne Baylor College of Medicine
Susan G. Hilsenbeck
Susan G. Hilsenbeck Baylor College of Medicine
Chad J. Creighton
Chad J. Creighton Baylor College of Medicine
Chad A. Shaw
Chad A. Shaw Baylor College of Medicine
Myles Brown
Myles Brown Harvard University
Suzanne A. W. Fuqua
Suzanne A. W. Fuqua Baylor College of Medicine
Joe W. Gray
Joe W. Gray Oregon Health & Science University
Michael T. Lewis
Michael T. Lewis Baylor College of Medicine
Jorge S. Reis-Filho
Jorge S. Reis-Filho Memorial Sloan Kettering Cancer Center
Thomas F. Westbrook
Thomas F. Westbrook Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always require the traditional path. There are several online direct entry MSN programs for non-nurses, allowing career changers to fast-track into advanced nursing roles without a prior nursing degree.

For those concerned about competitiveness, knowing what is the easiest nursing program to get into can help you find options that align with your academic background and minimize application stress.

If you’re interested in healthcare but prefer non-clinical roles, many medical billing and coding schools online provide excellent training along with financial aid, leading to in-demand administrative positions.

Some students wish to avoid standardized testing. Luckily, you can find nursing schools that don’t require teas or hesi exams, opening doors to nursing education without the added barrier of entrance tests.

These flexible educational options can help you begin or advance a healthcare career, tailored to your skills, interests, and educational background.

Best Scientists Citing Rachel Schiff

Trending Scientists